PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 6, 2026Bioconjugate Chemistry0 citations

Targeted Protein Degradation Aims to Transform Brain Cancer Therapy

Harnessing Targeted Protein Degradation for Developing Brain Cancer Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

OMOsaid MuhammadSWSophie WhiteCDCarina Dumo

Discussion

Loading...

Member takes

Overview

This review discusses using targeted protein degradation methods to enhance therapies in brain cancer, indicating promising clinical trials.

Key Points

  • This review explores the potential of targeted protein degradation as a strategy for treating brain cancer.
  • Overview of protein degradation technologies applied to brain cancer
  • Discussion on three modalities: PROTACs, molecular glues, and LYTACs
  • Examination of synthesis and biological evaluation of degraders
  • Targeted protein degradation offers a novel therapeutic strategy for brain cancer treatments
  • Several classes of degraders are advancing into clinical trials
  • This approach may improve patient outcomes and quality of life

Cite This Study

Muhammad et al. (2026) studied this question.

synapsesocial.com/papers/69fa979b04f884e66b531735https://doi.org/10.1021/acs.bioconjchem.6c00123
View Full Paper
Ask AI
Bookmark
Share